Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma
NCT05322070: Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis	Recruiting	4	125	US	Fluocinolone Acetonide Intravitreal Implant 0.18 mg, YUTIQ 0.18 mg	Alimera Sciences, CBCC Global Research	Uveitis, Posterior	11/25	11/25
NCT05070728: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)	Terminated	3	12	US	Sham Injector, Sham Comparator, FAI Insert, Active Drug	EyePoint Pharmaceuticals, Inc.	Uveitis, Uveitis, Posterior, Uveitis, Intermediate	10/22	04/23
TYNI, NCT05486468: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment	Recruiting	3	30	US	Yutiq 0.18 MG Drug Implant, Sham Injection	Texas Retina Associates, Eye Point Pharmaceuticals	Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate	12/23	12/24
NCT04918121: A Study of Yutiq Steroid Insert During Glaucoma Tube Implant Surgery	Recruiting	1	5	US	Yutiq 0.18 MG Drug Implant	Sanjay Asrani	Glaucoma	12/24	12/24
NCT05592717: A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis	Recruiting	N/A	15	RoW	Yutiq	Tianjin Medical University	Uveitis, YUTIQ	11/25	11/26